Cargando…

Impact of spike genetic variants in vaccines against SARS-CoV-2()

Detalles Bibliográficos
Autores principales:	Reina, J., Fraile-Ribot, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier España, S.L.U. 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192296/ http://dx.doi.org/10.1016/j.vacune.2021.05.001

Ejemplares similares

Impacto de las variantes genéticas de la espícula en las vacunas frente al SARS-CoV-2
por: Reina, J., et al.
Publicado: (2021)

Possible effect of the “original antigenic sin” in vaccination against new variants of SARS-CoV-2()
por: Reina, J.
Publicado: (2022)

Influenza vaccination in the time of SARS-CoV-2()
por: Reina, Jordi
Publicado: (2021)

SARS-CoV-2 variants – Evolution, spike protein, and vaccines
por: Chen, Kai-Wei K., et al.
Publicado: (2022)

SARS-CoV-2 vaccine challenge based on spike glycoprotein against several new variants
por: Syahniar, Rike, et al.
Publicado: (2022)

Approaching Challenges Posed by SARS-CoV-2 Genetic Variants
por: de la Fuente, José
Publicado: (2022)

Spike mutations in SARS-CoV-2 AY sublineages of the Delta variant of concern: implications for the future of the pandemic
por: Focosi, Daniele, et al.
Publicado: (2022)

The third booster vaccination dose against COVID-19: indication for circulating SARS-CoV-2 variants
por: Rahimi, Farid, et al.
Publicado: (2021)

Resilience of Spike-Specific Immunity Induced by COVID-19 Vaccines against SARS-CoV-2 Variants
por: Ballesteros-Sanabria, Laura, et al.
Publicado: (2022)

Should we vaccinate children against SARS-CoV-2?
por: The Lancet Infectious Diseases
Publicado: (2021)

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

Vaccination against SARS-CoV-2 should be included in childhood vaccination programs
por: Petersen, Eskild, et al.
Publicado: (2021)

Special Issue “New Insights into Current and Future Vaccines against SARS-CoV-2 Variants of Concern and Interest”
por: Qu, Bingqian, et al.
Publicado: (2023)

The Spike of Concern—The Novel Variants of SARS-CoV-2
por: Winger, Anna, et al.
Publicado: (2021)

Chasing COVID-19 through SARS-CoV-2 spike glycoprotein
por: Saxena, Shailendra K., et al.
Publicado: (2020)

Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern
por: Shi, Juan, et al.
Publicado: (2022)

Incorporation of SARS-CoV-2 spike NTD to RBD protein vaccine improves immunity against viral variants
por: Montgomerie, Isabelle, et al.
Publicado: (2023)

Epidemiology and Characteristics of SARS-CoV-2 Variants of Concern: The Impacts of the Spike Mutations
por: Cocherie, Théophile, et al.
Publicado: (2022)

Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates
por: Pavot, Vincent, et al.
Publicado: (2022)

Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
por: Gómez, Carmen Elena, et al.
Publicado: (2021)

Conformational stability of SARS-CoV-2 glycoprotein spike variants
por: Arruda, Hiam R.S., et al.
Publicado: (2022)

SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
por: Martínez-Flores, Daniel, et al.
Publicado: (2021)

A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern
por: Brinkkemper, Mitch, et al.
Publicado: (2021)

Special Issue “Advances in Antiviral Agents against SARS-CoV-2 and Its Variants”
por: Esposito, Francesca, et al.
Publicado: (2023)

Mutation profile of SARS-CoV-2 spike protein and identification of potential multiple epitopes within spike protein for vaccine development against SARS-CoV-2
por: Paul, Debadrita, et al.
Publicado: (2021)

SARS-CoV-2 Omicron variant in cancer patients: an insight into the vaccine booster debate
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters
por: Liu, Xueqiao, et al.
Publicado: (2023)

SARS-CoV-2 spike therapeutic antibodies in the age of variants
por: Baum, Alina, et al.
Publicado: (2021)

SARS-CoV-2 variants, spike mutations and immune escape
por: Harvey, William T., et al.
Publicado: (2021)

Induction of neutralizing antibodies against SARS-CoV-2 variants by a multivalent mRNA-lipid nanoparticle vaccine encoding SARS-CoV-2/SARS-CoV Spike protein receptor-binding domains
por: Zhang, Qiong, et al.
Publicado: (2022)

Are the new SARS-CoV-2 variants resistant against the vaccine?
por: Abdalla, Mohnad, et al.
Publicado: (2021)

Genetic Variants and Protective Immunity against SARS-CoV-2
por: Rabaan, Ali A., et al.
Publicado: (2022)

SARS-CoV-2 variants of concern: the knowns and unknowns
por: Lessells, Richard J.
Publicado: (2021)

The emergence, dynamics and significance of SARS-CoV-2 variants
por: COLSON, Philippe, et al.
Publicado: (2022)

Evolution and Clinical Trend of SARS-CoV-2 Variants
por: Lorente-González, Miguel, et al.
Publicado: (2022)

Emerging SARS-CoV-2 variants: shooting the messenger
por: The Lancet Infectious Diseases
Publicado: (2022)

The time between vaccination and infection impacts immunity against SARS-CoV-2 variants
por: Bates, Timothy A., et al.
Publicado: (2023)

Implication of SARS-CoV-2 Immune Escape Spike Variants on Secondary and Vaccine Breakthrough Infections
por: Ahmad, Liyana
Publicado: (2021)

Music of Microbiota Against SARS CoV-2
por: Belojevic, Goran, et al.
Publicado: (2019)

Characterization of a Novel SARS-CoV-2 Genetic Variant with Distinct Spike Protein Mutations
por: Gladkikh, Anna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eguac4n4blvva9rj0ak4s9cgno